Agile Therapeutics Inc. (AGRX)
NASDAQ: AGRX
· Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM
Agile Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.85M | 2.62M | 2.56M | 2.87M | 2.79M | 4.43M | 5.25M | 6.14M | 13.03M | 3.74M | 19.14M | 14.73M | 26.12M | 16.46M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 23.65M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 238K | 238K | 238K | 238K | 238K | 2.01M | 2.01M | 2.01M | 2.01M | 2.01M | 2.01M | 1.97M | 1.9M | 1.9M |
Receivables | 4.55M | 4.81M | 3.39M | 3.52M | 4.46M | 3.12M | 3.38M | 3.71M | 2.09M | 6.34M | 1.53M | 1.31M | 1.17M | 322K |
Inventory | 5.79M | 3.75M | 2.74M | 2.41M | 2.54M | 2.21M | 1.33M | 1.8M | 2.34M | 2.69M | 966K | 3.46M | 3.46M | 1.59M |
Other Current Assets | 1.12M | 631K | 402K | 562K | 898K | 1.14M | 1.4M | 3.83M | 817K | 968K | 1.51M | 2.26M | 1.2M | 1.65M |
Total Current Assets | 14.44M | 11.99M | 9.53M | 10.06M | 11.65M | 10.91M | 11.36M | 15.49M | 18.47M | 14.35M | 23.93M | 21.76M | 36.95M | 43.67M |
Property-Plant & Equipment | 282K | 385K | 487K | 587K | 684K | 779K | 872K | 964K | 12.35M | 12.94M | 13.4M | 12.95M | 13.44M | 13.91M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 520K | 623K | 725K | 825K | 922K | 2.79M | 2.88M | 2.98M | 14.36M | 14.95M | 15.41M | 14.92M | 15.33M | 15.8M |
Total Assets | 14.96M | 12.61M | 10.26M | 10.89M | 12.57M | 13.7M | 14.24M | 18.46M | 32.83M | 29.3M | 39.33M | 36.68M | 52.28M | 59.48M |
Account Payables | 16.54M | 12.62M | 9.57M | 6.88M | 6.16M | 10.36M | 7.73M | 4.91M | 12.04M | 9.54M | 8.71M | 5.63M | 6.41M | 5.94M |
Deferred Revenue | n/a | n/a | -1.71M | n/a | n/a | n/a | n/a | n/a | -12.87M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 1.71M | 2.32M | 2.06M | 1.84M | 1.43M | 1.59M | 12.87M | 12.48M | 17.01M | 37K | 72K | 106K |
Other Current Liabilities | 954K | 908K | 832K | 2.37M | 2.24M | 1.18M | 833K | 1.68M | 1.31M | 1.74M | 1.91M | 905K | 1.32M | 558K |
Total Current Liabilities | 26.23M | 21.44M | 20.78M | 17.54M | 15.31M | 18.51M | 13.39M | 11.65M | 28.78M | 25.85M | 29.28M | 9.57M | 11.63M | 8.79M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.43M | 16.04M | 15.64M |
Other Long-Term Liabilities | 10.65M | 1.49M | 5.7M | 5.57M | 9.1M | 4.25M | 5.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 10.65M | 1.49M | 5.8M | 5.76M | 9.38M | 4.63M | 6.4M | 550K | 630K | 708K | 784K | 16.43M | 16.04M | 15.64M |
Total Liabilities | 36.88M | 22.93M | 26.57M | 23.3M | 24.69M | 23.13M | 19.79M | 12.2M | 29.41M | 26.56M | 30.06M | 26M | 27.67M | 24.42M |
Total Debt | 289K | 378K | 2.17M | 2.52M | 2.69M | 2.22M | 2.21M | 2.15M | 13.5M | 13.19M | 17.79M | 16.47M | 16.11M | 15.74M |
Common Stock | 5K | 5K | 4K | n/a | n/a | n/a | 4K | 4K | 1K | n/a | 12K | 9K | 9K | 9K |
Retained Earnings | -433.76M | -421.88M | -423.17M | -418.7M | -417.9M | -414.09M | -408.7M | -430.77M | -411.11M | -398.89M | -387.12M | -363.76M | -346.99M | -329.35M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -21.91M | -10.32M | -16.32M | -12.41M | -12.12M | -9.43M | -5.54M | 6.26M | 3.42M | 2.74M | 9.27M | 10.68M | 24.61M | 35.05M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 23.65M |